 | • レポートコード：MRC23Q36350 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、60ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のセプチン9メチル化結腸直腸がん検出市場について調査・分析し、世界のセプチン9メチル化結腸直腸がん検出市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（科学用、臨床用）、用途別セグメント分析（病院、クリニック、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Epigenomics AG、MicroDiag Biomedicine、TE GEN、Biochain(Beijing)Science-Technologyなどが含まれています。世界のセプチン9メチル化結腸直腸がん検出市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、セプチン9メチル化結腸直腸がん検出市場規模を推定する際に考慮しました。本レポートは、セプチン9メチル化結腸直腸がん検出の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、セプチン9メチル化結腸直腸がん検出に関するビジネス上の意思決定に役立てることを目的としています。 ・セプチン9メチル化結腸直腸がん検出市場の概要 - セプチン9メチル化結腸直腸がん検出のタイプ別セグメント - 世界のセプチン9メチル化結腸直腸がん検出市場規模：タイプ別分析（科学用、臨床用） - セプチン9メチル化結腸直腸がん検出の用途別セグメント - 世界のセプチン9メチル化結腸直腸がん検出市場規模：用途別分析（病院、クリニック、その他） - 世界のセプチン9メチル化結腸直腸がん検出市場規模予測（2018年-2029年） ・セプチン9メチル化結腸直腸がん検出市場の成長トレンド - セプチン9メチル化結腸直腸がん検出の地域別市場規模（2018年-2029年） - セプチン9メチル化結腸直腸がん検出市場ダイナミクス - セプチン9メチル化結腸直腸がん検出の業界動向 - セプチン9メチル化結腸直腸がん検出市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：科学用、臨床用 - 世界のセプチン9メチル化結腸直腸がん検出のタイプ別市場規模（2018年-2023年） - 世界のセプチン9メチル化結腸直腸がん検出のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、クリニック、その他 - 世界のセプチン9メチル化結腸直腸がん検出の用途別市場規模（2018年-2023年） - 世界のセプチン9メチル化結腸直腸がん検出の用途別市場規模（2024年-2029年） ・セプチン9メチル化結腸直腸がん検出の地域別市場規模 - 北米のセプチン9メチル化結腸直腸がん検出市場規模（2018年-2029年） - アメリカのセプチン9メチル化結腸直腸がん検出市場規模（2018年-2029年） - ヨーロッパのセプチン9メチル化結腸直腸がん検出市場規模（2018年-2029年） - アジア太平洋のセプチン9メチル化結腸直腸がん検出市場規模（2018年-2029年） - 中国のセプチン9メチル化結腸直腸がん検出市場規模（2018年-2029年） - 日本のセプチン9メチル化結腸直腸がん検出市場規模（2018年-2029年） - 韓国のセプチン9メチル化結腸直腸がん検出市場規模（2018年-2029年） - インドのセプチン9メチル化結腸直腸がん検出市場規模（2018年-2029年） - オーストラリアのセプチン9メチル化結腸直腸がん検出市場規模（2018年-2029年） - 中南米のセプチン9メチル化結腸直腸がん検出市場規模（2018年-2029年） - 中東・アフリカのセプチン9メチル化結腸直腸がん検出市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Epigenomics AG、MicroDiag Biomedicine、TE GEN、Biochain(Beijing)Science-Technology ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Septin 9 Methylated Colorectal Cancer Detection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Septin 9 Methylated Colorectal Cancer Detection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Septin 9 Methylated Colorectal Cancer Detection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Septin 9 Methylated Colorectal Cancer Detection in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Septin 9 Methylated Colorectal Cancer Detection include Epigenomics AG, MicroDiag Biomedicine, TE GEN and Biochain(Beijing)Science-Technology, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Septin 9 Methylated Colorectal Cancer Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Septin 9 Methylated Colorectal Cancer Detection.
The Septin 9 Methylated Colorectal Cancer Detection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Septin 9 Methylated Colorectal Cancer Detection market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Septin 9 Methylated Colorectal Cancer Detection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Epigenomics AG
MicroDiag Biomedicine
TE GEN
Biochain(Beijing)Science-Technology
Segment by Type
Scientific Use
Clinic Use
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Septin 9 Methylated Colorectal Cancer Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Septin 9 Methylated Colorectal Cancer Detection Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Scientific Use
1.2.3 Clinic Use
1.3 Market by Application
1.3.1 Global Septin 9 Methylated Colorectal Cancer Detection Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Septin 9 Methylated Colorectal Cancer Detection Market Perspective (2018-2029)
2.2 Septin 9 Methylated Colorectal Cancer Detection Growth Trends by Region
2.2.1 Global Septin 9 Methylated Colorectal Cancer Detection Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Septin 9 Methylated Colorectal Cancer Detection Historic Market Size by Region (2018-2023)
2.2.3 Septin 9 Methylated Colorectal Cancer Detection Forecasted Market Size by Region (2024-2029)
2.3 Septin 9 Methylated Colorectal Cancer Detection Market Dynamics
2.3.1 Septin 9 Methylated Colorectal Cancer Detection Industry Trends
2.3.2 Septin 9 Methylated Colorectal Cancer Detection Market Drivers
2.3.3 Septin 9 Methylated Colorectal Cancer Detection Market Challenges
2.3.4 Septin 9 Methylated Colorectal Cancer Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Septin 9 Methylated Colorectal Cancer Detection Players by Revenue
3.1.1 Global Top Septin 9 Methylated Colorectal Cancer Detection Players by Revenue (2018-2023)
3.1.2 Global Septin 9 Methylated Colorectal Cancer Detection Revenue Market Share by Players (2018-2023)
3.2 Global Septin 9 Methylated Colorectal Cancer Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Septin 9 Methylated Colorectal Cancer Detection Revenue
3.4 Global Septin 9 Methylated Colorectal Cancer Detection Market Concentration Ratio
3.4.1 Global Septin 9 Methylated Colorectal Cancer Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Septin 9 Methylated Colorectal Cancer Detection Revenue in 2022
3.5 Septin 9 Methylated Colorectal Cancer Detection Key Players Head office and Area Served
3.6 Key Players Septin 9 Methylated Colorectal Cancer Detection Product Solution and Service
3.7 Date of Enter into Septin 9 Methylated Colorectal Cancer Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Septin 9 Methylated Colorectal Cancer Detection Breakdown Data by Type
4.1 Global Septin 9 Methylated Colorectal Cancer Detection Historic Market Size by Type (2018-2023)
4.2 Global Septin 9 Methylated Colorectal Cancer Detection Forecasted Market Size by Type (2024-2029)
5 Septin 9 Methylated Colorectal Cancer Detection Breakdown Data by Application
5.1 Global Septin 9 Methylated Colorectal Cancer Detection Historic Market Size by Application (2018-2023)
5.2 Global Septin 9 Methylated Colorectal Cancer Detection Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Septin 9 Methylated Colorectal Cancer Detection Market Size (2018-2029)
6.2 North America Septin 9 Methylated Colorectal Cancer Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Septin 9 Methylated Colorectal Cancer Detection Market Size by Country (2018-2023)
6.4 North America Septin 9 Methylated Colorectal Cancer Detection Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Septin 9 Methylated Colorectal Cancer Detection Market Size (2018-2029)
7.2 Europe Septin 9 Methylated Colorectal Cancer Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Septin 9 Methylated Colorectal Cancer Detection Market Size by Country (2018-2023)
7.4 Europe Septin 9 Methylated Colorectal Cancer Detection Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Septin 9 Methylated Colorectal Cancer Detection Market Size (2018-2029)
8.2 Asia-Pacific Septin 9 Methylated Colorectal Cancer Detection Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Septin 9 Methylated Colorectal Cancer Detection Market Size by Region (2018-2023)
8.4 Asia-Pacific Septin 9 Methylated Colorectal Cancer Detection Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Septin 9 Methylated Colorectal Cancer Detection Market Size (2018-2029)
9.2 Latin America Septin 9 Methylated Colorectal Cancer Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Septin 9 Methylated Colorectal Cancer Detection Market Size by Country (2018-2023)
9.4 Latin America Septin 9 Methylated Colorectal Cancer Detection Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Septin 9 Methylated Colorectal Cancer Detection Market Size (2018-2029)
10.2 Middle East & Africa Septin 9 Methylated Colorectal Cancer Detection Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Septin 9 Methylated Colorectal Cancer Detection Market Size by Country (2018-2023)
10.4 Middle East & Africa Septin 9 Methylated Colorectal Cancer Detection Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Epigenomics AG
11.1.1 Epigenomics AG Company Detail
11.1.2 Epigenomics AG Business Overview
11.1.3 Epigenomics AG Septin 9 Methylated Colorectal Cancer Detection Introduction
11.1.4 Epigenomics AG Revenue in Septin 9 Methylated Colorectal Cancer Detection Business (2018-2023)
11.1.5 Epigenomics AG Recent Development
11.2 MicroDiag Biomedicine
11.2.1 MicroDiag Biomedicine Company Detail
11.2.2 MicroDiag Biomedicine Business Overview
11.2.3 MicroDiag Biomedicine Septin 9 Methylated Colorectal Cancer Detection Introduction
11.2.4 MicroDiag Biomedicine Revenue in Septin 9 Methylated Colorectal Cancer Detection Business (2018-2023)
11.2.5 MicroDiag Biomedicine Recent Development
11.3 TE GEN
11.3.1 TE GEN Company Detail
11.3.2 TE GEN Business Overview
11.3.3 TE GEN Septin 9 Methylated Colorectal Cancer Detection Introduction
11.3.4 TE GEN Revenue in Septin 9 Methylated Colorectal Cancer Detection Business (2018-2023)
11.3.5 TE GEN Recent Development
11.4 Biochain(Beijing)Science-Technology
11.4.1 Biochain(Beijing)Science-Technology Company Detail
11.4.2 Biochain(Beijing)Science-Technology Business Overview
11.4.3 Biochain(Beijing)Science-Technology Septin 9 Methylated Colorectal Cancer Detection Introduction
11.4.4 Biochain(Beijing)Science-Technology Revenue in Septin 9 Methylated Colorectal Cancer Detection Business (2018-2023)
11.4.5 Biochain(Beijing)Science-Technology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details